Related Experiment Video
Updated: Dec 19, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Avenanthramide C suppresses hypoxia-induced cyclooxygenase-2 expression through sirtuin1 activation in non-small-cell
Wonchung Lim1, Chounghun Kang2
1Department of Sports Medicine, College of Health Science, Cheongju University, Cheongju, South Korea.
Abstract:
Avenanthramide C (AVC), found mainly in oats, mediates anti-inflammatory activities by reducing the anti-inflammatory cytokine levels. This study investigated the effects of AVC on hypoxia-induced cyclooxygenase-2 (COX-2) expression in A549 cells. AVC suppressed the hypoxia-induced increase in COX-2 protein levels and promoter activity. We also observed that the effects of AVC were reversed by a SIRT1 inhibitor, indicating that the inhibitory effects of AVC on hypoxia-induced COX-2 expression are mediated by SIRT1. Therefore, AVC inhibits the hypoxic induction of COX-2 expression via SIRT1 activation. Our results suggest that AVC could be beneficial for preventing lung inflammation under hypoxia.
Insights
Avenanthramide C (AVC) from oats reduces inflammation. This study shows AVC inhibits hypoxia-induced cyclooxygenase-2 (COX-2) via SIRT1 activation, suggesting benefits for lung inflammation.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Avenanthramide C (AVC), a compound found in oats, exhibits anti-inflammatory properties.
- Hypoxia can induce cyclooxygenase-2 (COX-2) expression, contributing to inflammation.
- Understanding the molecular mechanisms regulating COX-2 under hypoxia is crucial for developing anti-inflammatory strategies.
Purpose of the Study:
- To investigate the effect of Avenanthramide C (AVC) on hypoxia-induced cyclooxygenase-2 (COX-2) expression in A549 lung cells.
- To elucidate the role of SIRT1 in mediating the effects of AVC on COX-2 expression.
Main Methods:
- A549 cells were exposed to hypoxia.
- The effects of AVC on COX-2 protein levels and promoter activity were assessed.
- The involvement of SIRT1 was examined using a SIRT1 inhibitor.
Main Results:
- AVC suppressed the hypoxia-induced increase in COX-2 protein levels.
- AVC reduced hypoxia-induced COX-2 promoter activity.
- The inhibitory effects of AVC on COX-2 were reversed by a SIRT1 inhibitor, indicating SIRT1 mediation.
Conclusions:
- Avenanthramide C inhibits hypoxia-induced COX-2 expression through SIRT1 activation.
- AVC demonstrates potential as a therapeutic agent for preventing lung inflammation associated with hypoxia.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Angiogenesis and Blood Supply
Positive Regulator Molecules
Abnormal Proliferation
